MUMBAI, India, March 7 -- Intellectual Property India has published a patent application (202418102248 A) filed by Abtis Co. Ltd., Gyeonggi, Republic of Korea, on Dec. 23, 2024, for 'site-specific antibody conjugation and antibody-drug conjugate as specific example thereof.'
Inventor(s) include Chung, Sang Jeon; Kim, Ju Hwan; Lee, Young Geun; Lee, Tae Jin; and Seo, Jin Woo.
The application for the patent was published on March 7, under issue no. 10/2025.
According to the abstract released by the Intellectual Property India: "This application is divided out of Indian Application 202117040230 dated 06 September 2021. The present application relates to a technology enabling a specific number of chemical functional groups or cargo moieties t...